1.
Fill in the blanks: According to the DSM-V (through future-magic) the diagnosis of ADHD in patient <17 years old requires ______ symptoms and the diagnosis of ADHD in patients >17 years old requires ______ symptoms.
A. 
B. 
C. 
D. 
E. 
F. 
G. 
H. 
I. 
2.
Genetics plays a significant role in ADHD etiology.
3.
>70% of cases are genes associated with ADHD
4.
Which neurotransmitters are KNOWN to be involved in ADHD? (Select all that apply)
A. 
B. 
C. 
D. 
E. 
5.
Methylphenidate (MPD) decreases dopamine and norepinephrine levels by inhibiting monoamine transporters. Specifically, decreasing dopamine causes improved signal-to-noise ratio improving attention span.
6.
Which medication blocks dopamine transporters, preventing uptake from the synaptic cleft?
7.
Which medication increases synaptic cleft levels of dopamine?
8.
In addition to dopamine modification, what effect do Amphetamine and Methlyphenidate have on neuroanatomy of Norepinephrine neurons?
A. 
Suppress locus coeruleus NE neurons
B. 
Activate locus coeruleus NE neurons
C. 
Suppress decimus meridius NE neurons
D. 
Activate decimus meridius NE neurons
9.
Which qualities of bupropion (Wellbutrin) is FALSE?
A. 
Selective Norepinephrine reuptake inhibitor
B. 
C. 
Lacks potential for abuse
D. 
Does have risk of seizures
10.
Which of the following is TRUE about Atomoxetine (Strattera)?
A. 
Up to 3 weeks (5 half lives) to have full effect
B. 
Moderate potential for abuse
C. 
Only drug approved by the FDA for adult ADHD
D. 
Requires multiple daily dosing at maintenance levels
11.
Alpha-2-Adrenoceptor agonists (clonidine and guanfacine) _____ NE release in the locum coeruleus
12.
Which Methylphenidate mediation has an osmotic release, which extends its effect up to 12 hours?
A. 
B. 
C. 
D. 
13.
The transdermal methylphenidate patch is as effective as other formulations
14.
Focalin (or Dexmethlyphenidate) contains only the d-isomer of methylphenidate. As a result, the dose is 50% lower than methylphenidate and while efficacy is the same, tolerability of the medication is increased.
15.
Which of the follow would NOT be consider a common, specific adverse effect of stimulants?
A. 
B. 
C. 
D. 
16.
When would atomoxetine (Strattera) NOT be an alternative 1st line treatment?
A. 
B. 
Intolerance to methylphenidate
C. 
D. 
17.
Which of the follow is not a precaution in use of atomoxetine (Strattera)?
A. 
B. 
C. 
D. 
18.
What is the starting/titration dose of atomoxetine (Straterra)?
A. 
B. 
C. 
D. 
19.
When treatment with Stimulants results in increased tics, treatment for ADHD with clonidine (catapres) can be considered.
20.
Within how long is typical onset of guanfacine treatment in ADHD experienced?
A. 
B. 
C. 
D. 
21.
Which of the following statements about ADHD in children is FALSE?
A. 
90% respond to stimulant(s) alone
B. 
Long-acting formulations are more preferred
C. 
Lower doses for hyperactive type ADHD, higher doses for inattentive or combined form
D. 
Medications are best studied in this age group
22.
In treatment of major depressive disorder in pediatric patients, combination cognitive behavior therapy and SSRI are better than either treatment alone
23.
Which of the following SSRI is NOT expert recommended in treatment of major depressive disorder in pediatric patients?
A. 
B. 
C. 
D. 
24.
Which of the following is NOT a characteristic of Autism Spectrum Disorders?
A. 
B. 
Impaired nonverbal/verbal communication
C. 
Impaired social interactions
D. 
25.
Which medication is FDA approved as a pharmacologic option for Autism Spectrum Disorders?
A. 
B. 
C. 
D.